Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for March 9th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 9th:
BioCryst Pharmaceuticals, Inc. (BCRX - Free Report) : This biotechnology company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.6% over the last 60 days.
BioCryst Pharmaceuticals, Inc. Price and Consensus
BioCryst Pharmaceuticals, Inc. price-consensus-chart | BioCryst Pharmaceuticals, Inc. Quote
BioCryst Pharmaceuticals’ shares gained 38.4% over the last one month above the S&P 500’s decrease of 11.3%. The company possesses a Momentum Score of A.
BioCryst Pharmaceuticals, Inc. Price
BioCryst Pharmaceuticals, Inc. price | BioCryst Pharmaceuticals, Inc. Quote
Kinross Gold Corporation (KGC - Free Report) : This explorer, acquirer and developer of gold properties has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19% over the last 60 days.
Kinross Gold Corporation Price and Consensus
Kinross Gold Corporation price-consensus-chart | Kinross Gold Corporation Quote
Kinross Gold’s shares gained 11.4% over the last one month. The company possesses a Momentum Score of A.
Kinross Gold Corporation Price
Kinross Gold Corporation price | Kinross Gold Corporation Quote
Livongo Health, Inc. : This provider of an integrated suite of solutions for the healthcare industry has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 31% over the last 60 days.
Livongo Health, Inc. Price and Consensus
Livongo Health, Inc. price-consensus-chart | Livongo Health, Inc. Quote
Livongo Health’s shares gained 12.6% over the last one month. The company possesses a Momentum Score of A.
Livongo Health, Inc. Price
Livongo Health, Inc. price | Livongo Health, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>